More Cosciens Biopharma Inc. news Cosciens Biopharma Inc.TSX: CSCI Aeterna Zentaris Announces Exercise of Series B Warrants Nov 12, 2015 at 5:54 PM UTC · Issued by Cosciens Biopharma Inc. As issuedPlain English Philip Theodore, Senior Vice President, ptheodore@aezsinc.comCopyright CNW Group 2015
